ArticleBMC endocrine disorders2019
Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria.
Article in BMC endocrine disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 13 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
99 citing papers in PubMed, 13 syntheses or guidelines pooled it.
- Prevalence and Associated Factors of Sarcopenic Obesity in the Community Elderly: Meta-Analysis and Systematic Review.Nutrients · 2026Pooled it
- Comparative effectiveness and dose-response relationship of exercise-based interventions for muscle mass in older women with sarcopenia: a systematic review and network meta-analysis.Frontiers in medicine · 2026Pooled it
- Sex-stratified handgrip strength and adipose-derived inflammatory biomarkers in sarcopenia - a systematic review and meta-analysis.BMC geriatrics · 2025Pooled it
- Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review.BMC cancer · 2025Pooled it
- Prevalence of Sarcopenic Obesity in Elderly Population: A Meta-Analysis.Current aging science · 2025Pooled it
- Prevalence of sarcopenic obesity in the older non-hospitalized population: a systematic review and meta-analysis.BMC geriatrics · 2024Pooled it
- Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis.BMC geriatrics · 2024Pooled it
- The effects of exercise training on body composition in postmenopausal women: a systematic review and meta-analysis.Frontiers in endocrinology · 2023Pooled it
- Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review.BMC public health · 2022Pooled it
- Pooled it
- Prevalence of sarcopenia in older Chinese adults: a systematic review and meta-analysis.BMJ open · 2021Pooled it
- The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression.Nutrients · 2021Pooled it
- Sex Differences in Adaptations in Muscle Strength and Size Following Resistance Training in Older Adults: A Systematic Review and Meta-analysis.Sports medicine (Auckland, N.Z.) · 2021Pooled it
- Dietary behaviour change intervention for managing sarcopenic obesity among community-dwelling older people: a pilot randomised controlled trial.BMC geriatrics · 2023Trial
- Review
- Age, Not Sex, Drives Sarcopenia Severity in Mexican Older Adults with a Health Insurance Plan.Geriatrics (Basel, Switzerland) · 2026Article
- Prevalence, influencing factors, and dementia outcome of sarcopenic obesity in China.Aging clinical and experimental research · 2026Article
- Association of red cell distribution width-to-albumin ratio with mortality in adults with low muscle mass: A retrospective cohort study.The Journal of international medical research · 2026Article
- Rethinking Low Handgrip Strength: Normative Values, Diagnostic Thresholds, and Sarcopenia Risk in Malaysian Older Adults.Clinical interventions in aging · 2026Article
- Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study.The Journal of clinical endocrinology and metabolism · 2025Article
39 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundSarcopenia and sarcopenic obesity (SO) have a greater impact on the elderly. This study aimed to explore whether there were sex differences in the prevalence and adverse outcomes of sarcopenia and SO in community-dwelling elderly individuals in East China.
methodsThis was a cross-sectional study that enrolled 213 males and 418 females aged > 65 years. Demographic characteristics, body composition, hand grip, gait speed, and indices of glucose and lipid metabolism were collected. Sarcopenia and SO were diagnosed using the Asian Working Group for Sarcopenia criteria.
results(1) The prevalence of sarcopenia was 19.2% in males and 8.6% in females. The prevalence of SO was 7.0% in males and 2.4% in females. (2) In males, the odds ratios (ORs) of osteoporosis and dyslipidemia in the SO group were 4.21-fold and 4.15-fold higher than those in the normal group, respectively. In females, the ORs of osteoporosis and hyperglycemia in the SO group were 1.12-fold and 4.21-fold higher than those in the normal group.
conclusionsMales were more likely to be sarcopenic and to have SO than females using the AWGS criteria. Females with SO were more likely to have higher blood glucose, whereas males with SO were more likely to have osteoporosis and dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.